Request for Covid-19 Impact Assessment of this Report
The United States Intravenous (IV) Ibuprofen market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Intravenous (IV) Ibuprofen market, reaching US$ million by the year 2028. As for the Europe Intravenous (IV) Ibuprofen landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Intravenous (IV) Ibuprofen players cover Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited, and Sandor Medicaids, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous (IV) Ibuprofen market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
100 mg Dose
200 mg Dose
400 mg Dose
800 mg Dose
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Pain
Fever
Inflammation
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous (IV) Ibuprofen Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Intravenous (IV) Ibuprofen by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Intravenous (IV) Ibuprofen by Country/Region, 2017, 2022 & 2028
2.2 Intravenous (IV) Ibuprofen Segment by Type
2.2.1 100 mg Dose
2.2.2 200 mg Dose
2.2.3 400 mg Dose
2.2.4 800 mg Dose
2.3 Intravenous (IV) Ibuprofen Sales by Type
2.3.1 Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)
2.3.2 Global Intravenous (IV) Ibuprofen Revenue and Market Share by Type (2017-2022)
2.3.3 Global Intravenous (IV) Ibuprofen Sale Price by Type (2017-2022)
2.4 Intravenous (IV) Ibuprofen Segment by Application
2.4.1 Pain
2.4.2 Fever
2.4.3 Inflammation
2.5 Intravenous (IV) Ibuprofen Sales by Application
2.5.1 Global Intravenous (IV) Ibuprofen Sale Market Share by Application (2017-2022)
2.5.2 Global Intravenous (IV) Ibuprofen Revenue and Market Share by Application (2017-2022)
2.5.3 Global Intravenous (IV) Ibuprofen Sale Price by Application (2017-2022)
3 Global Intravenous (IV) Ibuprofen by Company
3.1 Global Intravenous (IV) Ibuprofen Breakdown Data by Company
3.1.1 Global Intravenous (IV) Ibuprofen Annual Sales by Company (2020-2022)
3.1.2 Global Intravenous (IV) Ibuprofen Sales Market Share by Company (2020-2022)
3.2 Global Intravenous (IV) Ibuprofen Annual Revenue by Company (2020-2022)
3.2.1 Global Intravenous (IV) Ibuprofen Revenue by Company (2020-2022)
3.2.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Company (2020-2022)
3.3 Global Intravenous (IV) Ibuprofen Sale Price by Company
3.4 Key Manufacturers Intravenous (IV) Ibuprofen Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous (IV) Ibuprofen Product Location Distribution
3.4.2 Players Intravenous (IV) Ibuprofen Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Intravenous (IV) Ibuprofen by Geographic Region
4.1 World Historic Intravenous (IV) Ibuprofen Market Size by Geographic Region (2017-2022)
4.1.1 Global Intravenous (IV) Ibuprofen Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Intravenous (IV) Ibuprofen Annual Revenue by Geographic Region
4.2 World Historic Intravenous (IV) Ibuprofen Market Size by Country/Region (2017-2022)
4.2.1 Global Intravenous (IV) Ibuprofen Annual Sales by Country/Region (2017-2022)
4.2.2 Global Intravenous (IV) Ibuprofen Annual Revenue by Country/Region
4.3 Americas Intravenous (IV) Ibuprofen Sales Growth
4.4 APAC Intravenous (IV) Ibuprofen Sales Growth
4.5 Europe Intravenous (IV) Ibuprofen Sales Growth
4.6 Middle East & Africa Intravenous (IV) Ibuprofen Sales Growth
5 Americas
5.1 Americas Intravenous (IV) Ibuprofen Sales by Country
5.1.1 Americas Intravenous (IV) Ibuprofen Sales by Country (2017-2022)
5.1.2 Americas Intravenous (IV) Ibuprofen Revenue by Country (2017-2022)
5.2 Americas Intravenous (IV) Ibuprofen Sales by Type
5.3 Americas Intravenous (IV) Ibuprofen Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous (IV) Ibuprofen Sales by Region
6.1.1 APAC Intravenous (IV) Ibuprofen Sales by Region (2017-2022)
6.1.2 APAC Intravenous (IV) Ibuprofen Revenue by Region (2017-2022)
6.2 APAC Intravenous (IV) Ibuprofen Sales by Type
6.3 APAC Intravenous (IV) Ibuprofen Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intravenous (IV) Ibuprofen by Country
7.1.1 Europe Intravenous (IV) Ibuprofen Sales by Country (2017-2022)
7.1.2 Europe Intravenous (IV) Ibuprofen Revenue by Country (2017-2022)
7.2 Europe Intravenous (IV) Ibuprofen Sales by Type
7.3 Europe Intravenous (IV) Ibuprofen Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravenous (IV) Ibuprofen by Country
8.1.1 Middle East & Africa Intravenous (IV) Ibuprofen Sales by Country (2017-2022)
8.1.2 Middle East & Africa Intravenous (IV) Ibuprofen Revenue by Country (2017-2022)
8.2 Middle East & Africa Intravenous (IV) Ibuprofen Sales by Type
8.3 Middle East & Africa Intravenous (IV) Ibuprofen Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous (IV) Ibuprofen
10.3 Manufacturing Process Analysis of Intravenous (IV) Ibuprofen
10.4 Industry Chain Structure of Intravenous (IV) Ibuprofen
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous (IV) Ibuprofen Distributors
11.3 Intravenous (IV) Ibuprofen Customer
12 World Forecast Review for Intravenous (IV) Ibuprofen by Geographic Region
12.1 Global Intravenous (IV) Ibuprofen Market Size Forecast by Region
12.1.1 Global Intravenous (IV) Ibuprofen Forecast by Region (2023-2028)
12.1.2 Global Intravenous (IV) Ibuprofen Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravenous (IV) Ibuprofen Forecast by Type
12.7 Global Intravenous (IV) Ibuprofen Forecast by Application
13 Key Players Analysis
13.1 Cumberland Pharmaceuticals
13.1.1 Cumberland Pharmaceuticals Company Information
13.1.2 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered
13.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Cumberland Pharmaceuticals Main Business Overview
13.1.5 Cumberland Pharmaceuticals Latest Developments
13.2 Alveda Pharmaceuticals
13.2.1 Alveda Pharmaceuticals Company Information
13.2.2 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered
13.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Alveda Pharmaceuticals Main Business Overview
13.2.5 Alveda Pharmaceuticals Latest Developments
13.3 CSL Limited
13.3.1 CSL Limited Company Information
13.3.2 CSL Limited Intravenous (IV) Ibuprofen Product Offered
13.3.3 CSL Limited Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Limited Main Business Overview
13.3.5 CSL Limited Latest Developments
13.4 Sandor Medicaids
13.4.1 Sandor Medicaids Company Information
13.4.2 Sandor Medicaids Intravenous (IV) Ibuprofen Product Offered
13.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sandor Medicaids Main Business Overview
13.4.5 Sandor Medicaids Latest Developments
13.5 PT. Soho Industri Pharmasi
13.5.1 PT. Soho Industri Pharmasi Company Information
13.5.2 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product Offered
13.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 PT. Soho Industri Pharmasi Main Business Overview
13.5.5 PT. Soho Industri Pharmasi Latest Developments
13.6 Germin MED
13.6.1 Germin MED Company Information
13.6.2 Germin MED Intravenous (IV) Ibuprofen Product Offered
13.6.3 Germin MED Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Germin MED Main Business Overview
13.6.5 Germin MED Latest Developments
13.7 Grifols
13.7.1 Grifols Company Information
13.7.2 Grifols Intravenous (IV) Ibuprofen Product Offered
13.7.3 Grifols Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Grifols Main Business Overview
13.7.5 Grifols Latest Developments
13.8 Gloria Pharmaceuticals
13.8.1 Gloria Pharmaceuticals Company Information
13.8.2 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered
13.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Gloria Pharmaceuticals Main Business Overview
13.8.5 Gloria Pharmaceuticals Latest Developments
13.9 Al Nabeel International
13.9.1 Al Nabeel International Company Information
13.9.2 Al Nabeel International Intravenous (IV) Ibuprofen Product Offered
13.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Al Nabeel International Main Business Overview
13.9.5 Al Nabeel International Latest Developments
13.10 Laboratorios Valmorca
13.10.1 Laboratorios Valmorca Company Information
13.10.2 Laboratorios Valmorca Intravenous (IV) Ibuprofen Product Offered
13.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Laboratorios Valmorca Main Business Overview
13.10.5 Laboratorios Valmorca Latest Developments
14 Research Findings and Conclusion
Table 1. Intravenous (IV) Ibuprofen Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Intravenous (IV) Ibuprofen Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 100 mg Dose
Table 4. Major Players of 200 mg Dose
Table 5. Major Players of 400 mg Dose
Table 6. Major Players of 800 mg Dose
Table 7. Global Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)
Table 8. Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)
Table 9. Global Intravenous (IV) Ibuprofen Revenue by Type (2017-2022) & ($ million)
Table 10. Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2017-2022)
Table 11. Global Intravenous (IV) Ibuprofen Sale Price by Type (2017-2022) & (USD/Kg)
Table 12. Global Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)
Table 13. Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2022)
Table 14. Global Intravenous (IV) Ibuprofen Revenue by Application (2017-2022)
Table 15. Global Intravenous (IV) Ibuprofen Revenue Market Share by Application (2017-2022)
Table 16. Global Intravenous (IV) Ibuprofen Sale Price by Application (2017-2022) & (USD/Kg)
Table 17. Global Intravenous (IV) Ibuprofen Sales by Company (2020-2022) & (MT)
Table 18. Global Intravenous (IV) Ibuprofen Sales Market Share by Company (2020-2022)
Table 19. Global Intravenous (IV) Ibuprofen Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Intravenous (IV) Ibuprofen Revenue Market Share by Company (2020-2022)
Table 21. Global Intravenous (IV) Ibuprofen Sale Price by Company (2020-2022) & (USD/Kg)
Table 22. Key Manufacturers Intravenous (IV) Ibuprofen Producing Area Distribution and Sales Area
Table 23. Players Intravenous (IV) Ibuprofen Products Offered
Table 24. Intravenous (IV) Ibuprofen Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Intravenous (IV) Ibuprofen Sales by Geographic Region (2017-2022) & (MT)
Table 28. Global Intravenous (IV) Ibuprofen Sales Market Share Geographic Region (2017-2022)
Table 29. Global Intravenous (IV) Ibuprofen Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Intravenous (IV) Ibuprofen Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Intravenous (IV) Ibuprofen Sales by Country/Region (2017-2022) & (MT)
Table 32. Global Intravenous (IV) Ibuprofen Sales Market Share by Country/Region (2017-2022)
Table 33. Global Intravenous (IV) Ibuprofen Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Intravenous (IV) Ibuprofen Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Intravenous (IV) Ibuprofen Sales by Country (2017-2022) & (MT)
Table 36. Americas Intravenous (IV) Ibuprofen Sales Market Share by Country (2017-2022)
Table 37. Americas Intravenous (IV) Ibuprofen Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Intravenous (IV) Ibuprofen Revenue Market Share by Country (2017-2022)
Table 39. Americas Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)
Table 40. Americas Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)
Table 41. Americas Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)
Table 42. Americas Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2022)
Table 43. APAC Intravenous (IV) Ibuprofen Sales by Region (2017-2022) & (MT)
Table 44. APAC Intravenous (IV) Ibuprofen Sales Market Share by Region (2017-2022)
Table 45. APAC Intravenous (IV) Ibuprofen Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Intravenous (IV) Ibuprofen Revenue Market Share by Region (2017-2022)
Table 47. APAC Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)
Table 48. APAC Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)
Table 49. APAC Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)
Table 50. APAC Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2022)
Table 51. Europe Intravenous (IV) Ibuprofen Sales by Country (2017-2022) & (MT)
Table 52. Europe Intravenous (IV) Ibuprofen Sales Market Share by Country (2017-2022)
Table 53. Europe Intravenous (IV) Ibuprofen Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Intravenous (IV) Ibuprofen Revenue Market Share by Country (2017-2022)
Table 55. Europe Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)
Table 56. Europe Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)
Table 57. Europe Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)
Table 58. Europe Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Intravenous (IV) Ibuprofen Sales by Country (2017-2022) & (MT)
Table 60. Middle East & Africa Intravenous (IV) Ibuprofen Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Intravenous (IV) Ibuprofen Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Intravenous (IV) Ibuprofen Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Intravenous (IV) Ibuprofen Sales by Type (2017-2022) & (MT)
Table 64. Middle East & Africa Intravenous (IV) Ibuprofen Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Intravenous (IV) Ibuprofen Sales by Application (2017-2022) & (MT)
Table 66. Middle East & Africa Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Intravenous (IV) Ibuprofen
Table 68. Key Market Challenges & Risks of Intravenous (IV) Ibuprofen
Table 69. Key Industry Trends of Intravenous (IV) Ibuprofen
Table 70. Intravenous (IV) Ibuprofen Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Intravenous (IV) Ibuprofen Distributors List
Table 73. Intravenous (IV) Ibuprofen Customer List
Table 74. Global Intravenous (IV) Ibuprofen Sales Forecast by Region (2023-2028) & (MT)
Table 75. Global Intravenous (IV) Ibuprofen Sales Market Forecast by Region
Table 76. Global Intravenous (IV) Ibuprofen Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Intravenous (IV) Ibuprofen Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Intravenous (IV) Ibuprofen Sales Forecast by Country (2023-2028) & (MT)
Table 79. Americas Intravenous (IV) Ibuprofen Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Intravenous (IV) Ibuprofen Sales Forecast by Region (2023-2028) & (MT)
Table 81. APAC Intravenous (IV) Ibuprofen Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Intravenous (IV) Ibuprofen Sales Forecast by Country (2023-2028) & (MT)
Table 83. Europe Intravenous (IV) Ibuprofen Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Intravenous (IV) Ibuprofen Sales Forecast by Country (2023-2028) & (MT)
Table 85. Middle East & Africa Intravenous (IV) Ibuprofen Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Intravenous (IV) Ibuprofen Sales Forecast by Type (2023-2028) & (MT)
Table 87. Global Intravenous (IV) Ibuprofen Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Intravenous (IV) Ibuprofen Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Intravenous (IV) Ibuprofen Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Intravenous (IV) Ibuprofen Sales Forecast by Application (2023-2028) & (MT)
Table 91. Global Intravenous (IV) Ibuprofen Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Intravenous (IV) Ibuprofen Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Intravenous (IV) Ibuprofen Revenue Market Share Forecast by Application (2023-2028)
Table 94. Cumberland Pharmaceuticals Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors
Table 95. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered
Table 96. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 97. Cumberland Pharmaceuticals Main Business
Table 98. Cumberland Pharmaceuticals Latest Developments
Table 99. Alveda Pharmaceuticals Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors
Table 100. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered
Table 101. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 102. Alveda Pharmaceuticals Main Business
Table 103. Alveda Pharmaceuticals Latest Developments
Table 104. CSL Limited Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors
Table 105. CSL Limited Intravenous (IV) Ibuprofen Product Offered
Table 106. CSL Limited Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 107. CSL Limited Main Business
Table 108. CSL Limited Latest Developments
Table 109. Sandor Medicaids Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors
Table 110. Sandor Medicaids Intravenous (IV) Ibuprofen Product Offered
Table 111. Sandor Medicaids Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 112. Sandor Medicaids Main Business
Table 113. Sandor Medicaids Latest Developments
Table 114. PT. Soho Industri Pharmasi Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors
Table 115. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product Offered
Table 116. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 117. PT. Soho Industri Pharmasi Main Business
Table 118. PT. Soho Industri Pharmasi Latest Developments
Table 119. Germin MED Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors
Table 120. Germin MED Intravenous (IV) Ibuprofen Product Offered
Table 121. Germin MED Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 122. Germin MED Main Business
Table 123. Germin MED Latest Developments
Table 124. Grifols Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors
Table 125. Grifols Intravenous (IV) Ibuprofen Product Offered
Table 126. Grifols Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 127. Grifols Main Business
Table 128. Grifols Latest Developments
Table 129. Gloria Pharmaceuticals Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors
Table 130. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product Offered
Table 131. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 132. Gloria Pharmaceuticals Main Business
Table 133. Gloria Pharmaceuticals Latest Developments
Table 134. Al Nabeel International Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors
Table 135. Al Nabeel International Intravenous (IV) Ibuprofen Product Offered
Table 136. Al Nabeel International Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 137. Al Nabeel International Main Business
Table 138. Al Nabeel International Latest Developments
Table 139. Laboratorios Valmorca Basic Information, Intravenous (IV) Ibuprofen Manufacturing Base, Sales Area and Its Competitors
Table 140. Laboratorios Valmorca Intravenous (IV) Ibuprofen Product Offered
Table 141. Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 142. Laboratorios Valmorca Main Business
Table 143. Laboratorios Valmorca Latest Developments
List of Figures
Figure 1. Picture of Intravenous (IV) Ibuprofen
Figure 2. Intravenous (IV) Ibuprofen Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous (IV) Ibuprofen Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Intravenous (IV) Ibuprofen Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Intravenous (IV) Ibuprofen Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 100 mg Dose
Figure 10. Product Picture of 200 mg Dose
Figure 11. Product Picture of 400 mg Dose
Figure 12. Product Picture of 800 mg Dose
Figure 13. Global Intravenous (IV) Ibuprofen Sales Market Share by Type in 2021
Figure 14. Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2017-2022)
Figure 15. Intravenous (IV) Ibuprofen Consumed in Pain
Figure 16. Global Intravenous (IV) Ibuprofen Market: Pain (2017-2022) & (MT)
Figure 17. Intravenous (IV) Ibuprofen Consumed in Fever
Figure 18. Global Intravenous (IV) Ibuprofen Market: Fever (2017-2022) & (MT)
Figure 19. Intravenous (IV) Ibuprofen Consumed in Inflammation
Figure 20. Global Intravenous (IV) Ibuprofen Market: Inflammation (2017-2022) & (MT)
Figure 21. Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2017-2022)
Figure 22. Global Intravenous (IV) Ibuprofen Revenue Market Share by Application in 2021
Figure 23. Intravenous (IV) Ibuprofen Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Intravenous (IV) Ibuprofen Revenue Market Share by Company in 2021
Figure 25. Global Intravenous (IV) Ibuprofen Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Intravenous (IV) Ibuprofen Revenue Market Share by Geographic Region in 2021
Figure 27. Global Intravenous (IV) Ibuprofen Sales Market Share by Region (2017-2022)
Figure 28. Global Intravenous (IV) Ibuprofen Revenue Market Share by Country/Region in 2021
Figure 29. Americas Intravenous (IV) Ibuprofen Sales 2017-2022 (MT)
Figure 30. Americas Intravenous (IV) Ibuprofen Revenue 2017-2022 ($ Millions)
Figure 31. APAC Intravenous (IV) Ibuprofen Sales 2017-2022 (MT)
Figure 32. APAC Intravenous (IV) Ibuprofen Revenue 2017-2022 ($ Millions)
Figure 33. Europe Intravenous (IV) Ibuprofen Sales 2017-2022 (MT)
Figure 34. Europe Intravenous (IV) Ibuprofen Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Intravenous (IV) Ibuprofen Sales 2017-2022 (MT)
Figure 36. Middle East & Africa Intravenous (IV) Ibuprofen Revenue 2017-2022 ($ Millions)
Figure 37. Americas Intravenous (IV) Ibuprofen Sales Market Share by Country in 2021
Figure 38. Americas Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2021
Figure 39. United States Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Intravenous (IV) Ibuprofen Sales Market Share by Region in 2021
Figure 44. APAC Intravenous (IV) Ibuprofen Revenue Market Share by Regions in 2021
Figure 45. China Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Intravenous (IV) Ibuprofen Sales Market Share by Country in 2021
Figure 52. Europe Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2021
Figure 53. Germany Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Intravenous (IV) Ibuprofen Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2021
Figure 60. Egypt Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Intravenous (IV) Ibuprofen Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Intravenous (IV) Ibuprofen in 2021
Figure 66. Manufacturing Process Analysis of Intravenous (IV) Ibuprofen
Figure 67. Industry Chain Structure of Intravenous (IV) Ibuprofen
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...